InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Eade Katherine A., 董事. Officer active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 7 disclosures have been published. History available since 25 May 2021. The latest transaction was filed on 16 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Eade Katherine A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
110,000 股0Common StockSEC:0001104659-25-069051:0
45,872 股0Common StockSEC:0000921895-24-001305:0
25,554 股0Common StockSEC:0000921895-23-001329:0
38,259 股0Common StockSEC:0000921895-22-001801:0
2,525 股0Common StockSEC:0000921895-22-000031:0
1,401 股0Common StockSEC:0000921895-21-002899:0
14,400 股0Common StockSEC:0000921895-21-001510:0
7 条申报中的 7 条
About Eade Katherine A.
Katherine A. Eade is a Board Member at Harvard Bioscience Inc. She plays a key role in the governance of the company, contributing to strategic decision-making and the direction of the organization. Her experience and expertise in the life sciences sector are essential for the company's development and growth. As a board member, she actively participates in discussions regarding the company's performance and future initiatives.
